NSPR · InspireMD, Inc. · Analyst Estimates
$0.47
+0.01 (+2.86%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has concluded that there is substantial doubt about our ability to continue as a going concern, and our condensed financial statements for the quarter ended June 30, 2026 includes an explanatory paragraph as to our ability to continue as a going concern, which could prevent us from obtaining new financing on reasonable terms or at all.”View the 10-Q filed Aug 14, 2026
Market Cap
$21.15M
Shares
46.49M
Volume · Oct 28
524.8K
Avg daily vol (3M)
128.46K
Analyst Estimates
Compare analyst forecasts for InspireMD, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 12:46 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.63
|
-0.45
|
-0.13
|
3
|
-0.74
|
-0.74
|
-0.74
|
-0.74
|
0
|
0
|
2
|
2
|
|
Revenue
USD
Publication date not stated |
9.40M
|
9.80M
|
10.28M
|
3
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.52
|
-0.48
|
-0.45
|
3
|
-0.61
|
-0.61
|
-0.61
|
-0.61
|
0
|
0
|
3
|
3
|
|
Revenue
USD
Publication date not stated |
16.02M
|
20.13M
|
26.27M
|
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.16
|
-0.15
|
-0.15
|
3
|
-0.19
|
-0.19
|
-0.19
|
-0.19
|
0
|
0
|
3
|
3
|
|
Revenue
USD
Publication date not stated |
1.88M
|
2.00M
|
2.11M
|
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.14
|
-0.13
|
-0.12
|
3
|
-0.19
|
-0.19
|
-0.19
|
-0.19
|
0
|
0
|
3
|
3
|
|
Revenue
USD
Publication date not stated |
2.30M
|
2.66M
|
3.00M
|
3
|
— | — | — | — | — | — | — | — |